The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Fasinumab is from a class of drugs targeting nerve growth factor (NGF), which plays a central role in the regulation of pain signalling. The FDA had trials of NGF drugs on hold twice because of ...